Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 12:14 PM
Ignite Modification Date:
2025-12-26 @ 12:14 PM
NCT ID:
NCT03981900
Group ID:
EG000
Title:
Tofacitinib
Description:
Participants with rheumatoid arthritis who received tofacitinib were included in this observational study. The recommended dosage is one Tofacitinib 5 milligram (mg) tablet (immediate release tablets) twice daily or Tofacitinib 11 mg (extended-release tablets) once a day, the transition from one formulation to another is possible according to the recommendations mentioned in the summary of product characteristics (SmPC).
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
64
Serious Number At Risk:
309
Other Number Affected:
197
Other Number At Risk:
309
Study:
NCT03981900
Results Section:
NCT03981900
Adverse Events Module:
NCT03981900